Co-delivery of Bcl-2 siRNA and doxorubicin through gold nanoparticle-based delivery system for a combined cancer therapy approach-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Co-delivery of Bcl-2 siRNA and doxorubicin through gold nanoparticle-based delivery system for a combined cancer therapy approach

Published:2022-08 Issue: Volume:74 Page:103603
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Tunç Cansu Ümran^ORCID,Aydin Omer^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference47 articles.

1. Triple-negative Breast Cancer;Chu,2012

2. siRNA Drugs: Here to Stay;Rossi,2021

3. Bcl-2 Antisense Oligonucleotides: a Potential Novel Strategy for the Treatment of Breast Cancer, Seminars in Oncology;Nahta,2003

4. Role of Bcl‐2 Family Proteins in Apoptosis: Apoptosomes or Mitochondria?;Tsujimoto,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advances in non-viral nanoparticle-based gene therapy for effective management of cancer;Journal of Drug Delivery Science and Technology;2024-10

2. Non-viral vectors combined delivery of siRNA and anti-cancer drugs to reverse tumor multidrug resistance;Biomedicine & Pharmacotherapy;2024-09

3. Co-delivery of Bcl-2 siRNA and doxorubicin using liposome-incorporated poly(ε-caprolactone) /chitosan nanofibers for the treatment of lung cancer;Journal of Drug Delivery Science and Technology;2024-09

4. Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies;ACS Omega;2024-08-23

5. Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition;Molecules;2024-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3